FI923088A - Oktadekyl-(2-(n-metylpiperidino)-etyl)-fosfat och foerfarande foer dess framstaellning - Google Patents

Oktadekyl-(2-(n-metylpiperidino)-etyl)-fosfat och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI923088A
FI923088A FI923088A FI923088A FI923088A FI 923088 A FI923088 A FI 923088A FI 923088 A FI923088 A FI 923088A FI 923088 A FI923088 A FI 923088A FI 923088 A FI923088 A FI 923088A
Authority
FI
Finland
Prior art keywords
methylpiperidino
octadecyl
phosphate
ethyl
overfining
Prior art date
Application number
FI923088A
Other languages
English (en)
Other versions
FI108035B (fi
FI923088A0 (fi
Inventor
Wolfgang Schumacher
Juergen Engel
Gerhard Noessner
Bernhard Kutscher
Jurij Stekar
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of FI923088A0 publication Critical patent/FI923088A0/fi
Publication of FI923088A publication Critical patent/FI923088A/fi
Application granted granted Critical
Publication of FI108035B publication Critical patent/FI108035B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
FI923088A 1991-07-04 1992-07-03 Menetelmä terapeuttisesti käyttökelpoisen oktadekyyli-[2-(N-metyylipiperidino)etyyli]fosfaatin valmistamiseksi ja menetelmä sen puhdistamiseksi FI108035B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4122140 1991-07-04
DE4122140 1991-07-04
DE4129364 1991-09-04
DE4129364 1991-09-04

Publications (3)

Publication Number Publication Date
FI923088A0 FI923088A0 (fi) 1992-07-03
FI923088A true FI923088A (fi) 1993-01-05
FI108035B FI108035B (fi) 2001-11-15

Family

ID=25905206

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923088A FI108035B (fi) 1991-07-04 1992-07-03 Menetelmä terapeuttisesti käyttökelpoisen oktadekyyli-[2-(N-metyylipiperidino)etyyli]fosfaatin valmistamiseksi ja menetelmä sen puhdistamiseksi

Country Status (19)

Country Link
US (1) US5219866A (fi)
EP (1) EP0521353B1 (fi)
JP (1) JP3176720B2 (fi)
KR (1) KR100255436B1 (fi)
CN (1) CN1030658C (fi)
AT (1) ATE136783T1 (fi)
AU (1) AU651224B2 (fi)
CA (1) CA2073146C (fi)
DE (2) DE4219972A1 (fi)
DK (1) DK0521353T3 (fi)
EG (1) EG20082A (fi)
ES (1) ES2086026T3 (fi)
FI (1) FI108035B (fi)
GR (1) GR3019776T3 (fi)
HU (2) HUT61561A (fi)
IE (1) IE73200B1 (fi)
IL (1) IL102380A (fi)
NO (1) NO303939B1 (fi)
PL (3) PL173794B1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516036T1 (de) * 2002-07-30 2011-07-15 Fterna Zentaris Gmbh Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten
US8383605B2 (en) * 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用
JP5068630B2 (ja) * 2007-11-15 2012-11-07 オルガノ株式会社 アルコール含有溶液中のアルデヒド化合物の除去方法及び該方法により精製された醸造酒
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU301951A1 (ru) * 1970-06-01 1973-04-05 В. А. Чернов, Т. С. Сафонова, Н. В. Сазонов, А. А. Кропачева, Лекарственное средство
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE59208905D1 (de) * 1991-07-04 1997-10-23 Asta Medica Ag Verfahren zur Herstellung von Alkylphosphocholinen und Reinherstellung derselben

Also Published As

Publication number Publication date
AU1943592A (en) 1993-03-11
KR100255436B1 (ko) 2000-05-01
GR3019776T3 (en) 1996-07-31
FI108035B (fi) 2001-11-15
CN1030658C (zh) 1996-01-10
HU211483A9 (en) 1995-11-28
JP3176720B2 (ja) 2001-06-18
CA2073146A1 (en) 1993-01-05
AU651224B2 (en) 1994-07-14
CA2073146C (en) 2002-05-28
ATE136783T1 (de) 1996-05-15
ES2086026T3 (es) 1996-06-16
HU9202232D0 (en) 1992-10-28
DE4219972A1 (de) 1993-01-07
HUT61561A (en) 1993-01-28
DE59205998D1 (de) 1996-05-23
EP0521353A1 (de) 1993-01-07
PL173905B1 (pl) 1998-05-29
IE73200B1 (en) 1997-05-07
NO303939B1 (no) 1998-09-28
NO922642L (no) 1993-01-05
DK0521353T3 (da) 1996-05-13
NO922642D0 (no) 1992-07-03
EG20082A (en) 1997-05-31
FI923088A0 (fi) 1992-07-03
KR930001909A (ko) 1993-02-22
PL173794B1 (pl) 1998-05-29
IL102380A (en) 1996-10-16
IL102380A0 (en) 1993-01-14
PL295128A1 (en) 1993-08-23
PL173869B1 (pl) 1998-05-29
JPH05213980A (ja) 1993-08-24
US5219866A (en) 1993-06-15
IE922183A1 (en) 1993-01-13
EP0521353B1 (de) 1996-04-17
CN1068119A (zh) 1993-01-20

Similar Documents

Publication Publication Date Title
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
NO900612D0 (no) Preservativ for vandige sammensetninger.
DE69111681D1 (de) Elektronenoptische Messeinrichtung.
ITTO910567A0 (it) Derivati carbostirilici.
FI923088A (fi) Oktadekyl-(2-(n-metylpiperidino)-etyl)-fosfat och foerfarande foer dess framstaellning
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
IT1240318B (it) Formulazione emulsionante perfezionata
IT8024150A0 (it) Derivati di alovincamone eprocedimento per la loro preparazione.
FI923371A0 (fi) En farmaceutisk formulation.
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
MA22143A1 (fr) Derives de 1,5 benzothiazepinone, leurs preparations et leur application
DE69003056D1 (de) S-Alkylthiopropionsäuren und deren Derivate.
MX9102662A (es) Lamina de alta consistencia.
ES1008860Y (es) Tenaza perfeccionada.
DE69130099D1 (de) Antineoplastischer wirkstoff
DE69008686D1 (de) Pulverisiermühle.
MX9204164A (es) Composicion farmaceutica que comprende arndh.
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
ES1014445Y (es) Calcetin perfeccionado.
DE69005302D1 (de) Papierleimungszusammensetzungen.
ES1011290Y (es) Caballete perfeccionado.
KR900014543U (ko) 맥반석 정수기
NO911441L (no) Regioselektiv formyleringsfremgangsmaate.